This session concentrates on our own personal development including keys to success, burnout, achieving publications and presenting like a pro, followed by building a transplant team, including and developing protocols with case-based presentations.
Full Professor & Head of Clinical Unit of Paediatric Nephrology and Solid Organ Transplantation at Red Cross War Memorial Children’s Hospital, Cape Town, as well as a Senior Lecturer at the University of Cape Town, South Africa.
She is the Immediate Past-President of the International Paediatric Transplantation Society (IPTA) and Current President of the South African Paediatric Association (SAPA). Her interests include Paediatric Transplantation in Cape Town (coordinating paediatric renal and liver transplant services and establishing cardiac and lung transplant services). She has also developed an Adolescent transition clinic for renal transplant patients.
Her other interests include Paediatric Nephrology and Care of Critically ill children specifically with AKI requiring all forms of dialysis in infants and children. This includes doing training Fellows and outreach work in various parts of Africa developing paediatric renal and transplant programs. She has previously worked in paediatric renal units in the UK including Great Ormond Street Children’s, Evelina London Children’s Guys and Kings’ Hospitals.
She is also an Amateur surfer.
Katherine Twombley is a Professor with Tenure in the Department of Pediatrics at the Medical University of South Carolina (MUSC) in Charleston, SC in the USA. She is the Chief of Pediatric Nephrology and the Medical Director of the Pediatric Kidney Transplant Program. She is very active in the International Pediatric Transplantation Association. She is a former counselor and is the past chair of the education committee. She has also served on the membership committee. Her research has focused on AMR and she is currently one of the lead PIs on the PARAMOUr “PediAtric Renal AMr Outcomes” Study that has to date enrolled >100 pediatric patients with AMR.
Burkhard Tönshoff, MD, PhD, is professor of pediatrics and pediatric nephrology at the University Children’s Hospital Heidelberg, Germany and Vice Chairman of the Department of Pediatrics I. His current research focuses on various issues in acute and chronic kidney disease and renal transplantation. In the year 2009 he founded the Cooperative European Paediatric Renal Transplant Initiative (CERTAIN; www.certain-registry.eu) as a multicenter research network and platform built on a novel, web-based registry. Since 2018 he serves as Editor-in-Chief of the journal Pediatric Transplantation, the official journal of IPTA.
Professor Stephen Marks, MD MSc MRCP DCH FRCPCH is Professor of Paediatric Nephrology and Transplantation at University College London Great Ormond Street Institute of Child Health. He is clinical lead for renal transplantation and Director of the National Institute for Health Research Great Ormond Street Hospital Clinical Research Facility at Great Ormond Street Hospital for Children NHS Foundation Trust. He is currently theme lead for high intensity early phase clinical trials as well as PPIE for NIHR GOSH Biomedical Research Centre and chair of the British Association for Paediatric Nephrology and UK Renal Registry Audit and Informatics committee having previously been the chair of the National Health Service Blood and Transplant Paediatric Kidney Advisory Group. His research continues to date in the fields of renal transplantation (including innovative drug trials concerning new anti-rejection therapies and assessment of children post-renal transplantation), systemic lupus erythematosus and vasculitis. He is on the editorial board for British Journal of Renal Medicine and is associate editor for Transplantation, Pediatric Nephrology and Pediatric Transplantation, which are the journals of The Transplantation Society, the International Pediatric Nephrology Association and the International Pediatric Transplant Association (IPTA) respectively.
Anne I. Dipchand, MD is Professor of Paediatrics at the University of Toronto and a Paediatric Cardiologist and the head of the Heart Transplant Program at the Hospital for Sick Children (SickKids) in Toronto. Her clinical research activities are focused on paediatric heart failure and transplantation.
Dr. Dipchand is a Past-President of the International Paediatric Transplant Association (IPTA),and has been involved in multiple leadership positions in other organizations including the American Society of Transplantation, the International Heart and Lung Transplantation Society, the American Heart Association, the Canadian Cardiac Transplant Network, the Canadian Society of transplantation, amongst others. Dr. Dipchand is actively involved in clinical research. She is a co-Pl for an NIH-funded consortium looking at alloantibodies in paediatric heart transplantation. She has had a major focus on registrybased analyses, having been the President of the Pediatric Heart Transplant Society (PHTS) and the Associate Director - Paediatrics for the International Society of Heart and Lung Transplantation (ISHLT) Registry - the two major international registries for pediatric heart transplantation. She was the Chair of the International Pediatric Heart Failure Registry (iPHFR) and sat on the Executive Committee of the ISHLT Registry for Mechanically Assisted Circulatory Support (IMACS). Dr. Dipchand was the Founding President and CEO of the Pediatric Heart Transplant Society Foundation, a not-for-profit foundation dedicated to advancing the science and treatment of children with end-stage heart failure listed for or following a heart transplant. She also actively spearheads opportunities for children and families of children with organ transplantation including educational symposia and written educational materials.
Jun Oh MD is the director of the KfH Kidney Center for Children and Adolescents Hamburg and the head of the Department of Pediatric Nephrology, Ped. Gastroenterology and Ped. Transplantation at the Medical Center of the University Hamburg/Eppendorf, which is part of the European Reference Network for Rare Kidney Diseases (ERKNet) and the European Reference Network for Rare Liver Diseases (ERN-Rare Liver).
Jun's main interests in the field of basic science are the pathogeneses of proteinuria, complement associated renal diseases. He is participating in several translational transplantation projects. He is involved in several randomized controlled clinical trials, patient registries, and clinical practice recommendations.
Jun is treasurer and council member of the ESPN and GPN, and he has published over 90 original scientific articles, several reviews and editorials and book chapters.
Dr. Debra Lefkowitz is a pediatric transplant psychologist at The Children’s Hospital of Philadelphia (USA). She is currently is the Psychosocial Director for the Pediatric Transplant Center and the Clinical Director of the Pediatric Health and Behavior Program, and serves as the psychology and Transplant Center representative to the hospital’s Ethics Committee. She is also an Associate Professor of Clinical Psychology at the Perelman School of Medicine at the University of Pennsylvania.
Dr. Anna Gold is a registered clinical neuropsychologist with extensive experience assessing children, adolescents and adults. She specializes in working with clients who present with a variety of developmental, learning and mental health issues, in addition to complex medical and neurological profiles. She focuses on providing comprehensive assessment of academic, cognitive and executive abilities, whilst considering mental health and behavioural factors that may impact day-to-day functioning.
Dr. Anna Gold is a caring and thoughtful clinician, whose goal is to ensure that clients feel comfortable and confident throughout the assessment, ensuring that the most reliable and valid results are yielded. She aims to provide comprehensive evidence-based interventions and recommendations that can be easily and effectively implemented into the child’s home and school environments, hopefully facilitating long-term positive change. She is passionate about ensuring the child and family’s voice remains central throughout the assessment process, whilst ensuring that important details are gathered from educators and other community professionals, as appropriate.
Dr. Anna Gold completed her training in the United Kingdom: PhD in Clinical Psychology (University of East Anglia) and post-doctoral training in neuropsychology (Kings College, London), followed by her employment as a neuropsychologist in several hospitals in Oxford. She moved to Toronto in 2003, obtained registration with the College of Psychologist of Ontario (CPO) and began working as a staff psychologist at the Hospital for Sick Children in 2004, where she remains employed. She has clinical experience working with a range of pediatric populations (including oncology, movement disorder, epilepsy, cystic fibrosis, genetic/ metabolic disorders and solid organ transplantation), in addition to providing clinical training and supervision. She is actively involved in a range of professional organizations (e.g., International Pediatric Transplant Association, Intestinal Rehabilitation and Transplant Association), has published numerous peer reviewed articles and book chapters, and is an invited speaker at conferences on topics across pediatric neuropsychology.
Carlos O. Esquivel is Professor of Surgery at Stanford University School of Medicine, Chief of the Division of Abdominal Transplantation and the Associate Director of the Institute of Immunity, Transplantation and Infection, an umbrella institute that fosters interdisciplinary research between basic scientists and clinicians. Dr. Esquivel is the first recipient of the Arnold and Barbara Silverman Professorship in Transplantation. He received his M.D. degree from the University of Costa Rica School of Medicine, completed general surgery training at the University of California Davis and then obtained a doctoral degree from the University of Lund in Sweden. He trained in transplantation of the liver, kidney, pancreas and intestine at the University of Pittsburgh under the direction of Dr. Thomas Starzl. In 1995, he was recruited to Stanford to start the Pediatric Transplant Programs at LPCH and rebuild the Adult Liver and Kidney Transplant Program.
Dr. Esquivel is recognized worldwide as an expert and pioneer in transplantation. He is a creative and productive investigator having contributed 338 publications in the medical literature and given over 200 lectures throughout the United States and internationally. He oversees multiple basic science and clinical research projects and is currently PI for a 5-year, multi-center NIH grant to develop biomarkers for Epstein-Barr Virus-induced post-transplant lymphomas in children. As a transplant leader at Stanford and in key national and international societies, he promotes team cooperation, embraces change and creates an environment for fostering discovery, and for training leaders of the future. In recognition of his many contributions to surgical education, Dr. Esquivel received the American Society of Transplant Surgeons 2015 Francis Moore Excellence in Mentorship in the Field of Transplantation Award.
Dr. Jaime M Restrepo received his M.D. from Valle University in Cali- Colombia , completed Pediatric residency at the Antioquia University in Medellin- Colombia and obtained a Pediatric nephrology fellowship from the Harvard University in Boston under the direction of Dr Julie Ingelfinger and John T Herrin. Dr. Restrepo is recognized as an pioneer in pediatric nephrology and transplantation in Colombia. He has been working since 15 years ago with ISN through SRC and STC, setting up new services in the southwest of Colombia, increasing the teaching and clinical research in this part of Colombia. Dr. Restrepo participated in the IPTA Outreach programduring the January 2009- January 2013. He is also trained many residents and fellows from different regions in Colombia in clinical pediatric transplantation. He is at present member of Educational Committee of IPTA.
He trained for six years as a nephrologist and transplant physician at the Western Infirmary in Glasgow. Subsequently he worked as a Consultant Nephrologist with a special interest in transplantation at the University Hospital of North Staffordshire. During this period he developed an interest in non-adherence in young adult transplant recipients and transition of care from paediatric to adult care. He established a joint transition process with Birmingham Children's Hospital.
In 2002, Dr Harden joined the Oxford Kidney Unit and Transplant Centre and has continued to pursue his interest in transition, having established joint clinics with Great Ormond Street and Evelina Children's Hospitals in London. He is clinical advisor to the National Health Service in the UK on adolescent transition and young adult services in patients with ESRD. He runs a unique community-based young adult transplant service in Oxford.
In addition Paul Harden is interested in malignancy post-transplantation and the impact of targeted immunosuppression reduction. He is Chief Investigator of the RESCUE (UK) trial of immunosuppression modulation for squamous cell skin cancer post-transplantation. He is currently working with a European consortium on development of a trial of cell therapy to allow immunosuppression reduction.
Beverly is the Clinical Nurse Specialist in Transplant Surgery at Children’s Hospital of Pittsburgh. She works with patients and families throughout the transplant process from evaluation to transition to adult care. As Transition Program Specialist for MyPATH, a program for teen liver and intestine recipients, she works with the multidisciplinary team to help youth develop skills to prepare for transfer to adult providers. Beverly has spoken internationally on pediatric transplant topics and transition of care and has authored several articles, book chapters, and nursing and patient educational materials. She is an active member of IPTA, IRTA, AST and ITNS and has served on various committees as well as being a board member for IRTA and ITNS. Beverly is a Fellow in the American Academy of Nursing (FAAN) and Director of Camp Chihopi, an annual camping event for transplant recipients
J Jenny Prüfe, PhD, MPhil (cantab), Dipl. Reha-Päd is heading the psychosocial services at University Children’s Hospital Essen. From 2012-2019 has been post-doctoral researcher and clinical scientist at MHH (Medical School Hannover). Jenny’s research focusses on childhood development in the context of severe disease. She has particular interest is in aspects of cognition, adherence, and transition into adulthood of young people following solid organ transplantation.
LLisa received a bachelor’s degree in nursing science from the University of Michigan. She received her Certified Clinical Transplant Coordinator certification in 1996 and this remains current. Lisa has over 30 years of experience in the field of transplantation including as a staff nurse, and transplant coordinator. She has worked at the Transplant Pregnancy Registry International as research coordinator for the past 24 years. Lisa has written and co-authored many chapters and journal articles. She has also presented numerous abstracts at national and international meetings.
He trained for six years as a nephrologist and transplant physician at the Western Infirmary in Glasgow. Subsequently he worked as a Consultant Nephrologist with a special interest in transplantation at the University Hospital of North Staffordshire. During this period he developed an interest in non-adherence in young adult transplant recipients and transition of care from paediatric to adult care. He established a joint transition process with Birmingham Children's Hospital.
In 2002, Dr Harden joined the Oxford Kidney Unit and Transplant Centre and has continued to pursue his interest in transition, having established joint clinics with Great Ormond Street and Evelina Children's Hospitals in London. He is clinical advisor to the National Health Service in the UK on adolescent transition and young adult services in patients with ESRD. He runs a unique community-based young adult transplant service in Oxford.
In addition Paul Harden is interested in malignancy post-transplantation and the impact of targeted immunosuppression reduction. He is Chief Investigator of the RESCUE (UK) trial of immunosuppression modulation for squamous cell skin cancer post-transplantation. He is currently working with a European consortium on development of a trial of cell therapy to allow immunosuppression reduction.
Cell Transplant and Regenerative Medicine Society
c/o The Transplantation Society
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada